PR/Corporate Archives - Scientific Technology News

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities

The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world. Laboratories can now perform a wider range of tests on a single solution, simplifying laboratory logistics and helping to optimise the use of resources. Basel, 13 December... Read more

December 4, 2024 PR/Corporate

MKS Instruments Named One of America’s Most Responsible Companies

ANDOVER, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, was recognized today as one of America’s Most Responsible Companies for 2025 , presented by Newsweek and Statista, Inc. Read more

November 7, 2024 PAI Top-10 PR/Corporate

PacBio Announces Third Quarter 2024 Financial Results

MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2024. Third quarter results: Revenue of $40.0 million compared with $55.7 million in the prior-year period. Instrument revenue of $16.8 million compared with $34.7 million in the prior-year period. Instrument revenue in the... Read more

November 6, 2024 PR/Corporate

MKS Instruments Reports Third Quarter 2024 Financial Results

Quarterly revenue of $896 million, at the high end of guidance Quarterly GAAP net income of $62 million and net income per share of $0.92 Quarterly Adjusted EBITDA of $232 million and Non-GAAP net earnings per diluted share of $1.72, exceeding the high-end of guidance ANDOVER, Mass., Nov. Read more

November 5, 2024 PR/Corporate

MKS Instruments Announces Appointment of Wissam Jabre to its Board of Directors

ANDOVER, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that Wissam Jabre, EVP and Chief Financial Officer of Western Digital Corporation, has been appointed to its Board of Read more

November 5, 2024 Lab Top-10 PAI Top-10 PR/Corporate

Bruker Reports Third Quarter 2024 Financial Results

Q3 2024 revenues of $864.4 million, up 16.4% year-over-year (yoy); Bruker organic revenue up 3.1% yoy, and CER revenue up 15.7% yoy; BSI segment organic revenue up 3.8% yoy Q3 2024 GAAP diluted EPS $0.27; non-GAAP diluted EPS $0.60 Updated FY2024 guidance: Revenue $3.34 to $3.37 billion, implying Bruker organic revenue growth of 3% to... Read more

October 28, 2024 Lab Top-10 Life Science Tools PR/Corporate

Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast

Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2024 financial results before market opening on Tuesday, November 5, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the... Read more

October 23, 2024 Lab Top-10 PAI Top-10 PR/Corporate

Thermo Fisher Scientific Reports Third Quarter 2024 Results

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28, 2024. Third Quarter 2024 Highlights Third quarter revenue was $10.60 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.25. Third quarter adjusted EPS was $5.28. Advanced... Read more

October 23, 2024 PAI Top-10 PR/Corporate

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months

Group sales grew by 6%1 at constant exchange rates (CER) (2% in CHF) in the first nine months, driven by the high demand for both our medicines and diagnostics; excluding COVID-19-related products, sales increased by 8% In the third quarter, Group sales rose by 9% (6% in CHF), as they did in the second quarter... Read more

October 22, 2024 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Danaher Reports Third Quarter 2024 Results

WASHINGTON, Oct. 22, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended September 27, 2024. All results in this release reflect only continuing operations unless otherwise noted. Key Third Quarter 2024 Results Net earnings were $818 million, or $1.12 per diluted common share and non-GAAP adjusted diluted net earnings per... Read more